Protein model discrimination attempts using mutational sensitivity, predicted secondary structure, and model quality information.


Journal

Proteins
ISSN: 1097-0134
Titre abrégé: Proteins
Pays: United States
ID NLM: 8700181

Informations de publication

Date de publication:
04 2019
Historique:
received: 13 07 2018
revised: 22 12 2018
accepted: 02 01 2019
pubmed: 8 1 2019
medline: 4 4 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Structure prediction methods often generate a large number of models for a target sequence. Even if the correct fold for the target sequence is sampled in this dataset, it is difficult to distinguish it from other decoy structures. An attempt to solve this problem using experimental mutational sensitivity data for the CcdB protein was described previously by exploiting the correlation of residue depth with mutational sensitivity (r ~ 0.6). We now show that such a correlation extends to four other proteins with localized active sites, and for which saturation mutagenesis datasets exist. We also examine whether incorporation of predicted secondary structure information and the DOPE model quality assessment score, in addition to mutational sensitivity, improves the accuracy of model discrimination using a decoy dataset of 163 targets from CASP. Although most CASP models would have been subjected to model quality assessment prior to submission, we find that the DOPE score makes a substantial contribution to the observed improvement. We therefore also applied the approach to CcdB and four other proteins for which reliable experimental mutational data exist and observe that inclusion of experimental mutational data results in a small qualitative improvement in model discrimination relative to that seen with just the DOPE score. This is largely because of our limited ability to quantitatively predict effects of point mutations on in vivo protein activity. Further improvements in the methodology are required to facilitate improved utilization of single mutant data.

Identifiants

pubmed: 30615225
doi: 10.1002/prot.25654
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-336

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Shruti Khare (S)

Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.

Munmun Bhasin (M)

Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.

Anusmita Sahoo (A)

Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.

Raghavan Varadarajan (R)

Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Chemical Biology Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH